Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study

J Trigo, D García-Azorín, Á Planchuelo-Gómez… - The journal of headache …, 2020 - Springer
Introduction Headache is one of the most frequent neurologic manifestations in COVID-19.
We aimed to analyze which symptoms and laboratory abnormalities were associated with …

IL-4/IL-13 remodeling pathway of COVID-19 lung injury

CB Vaz de Paula, MLV de Azevedo, S Nagashima… - Scientific Reports, 2020 - nature.com
The COVID-19 fatality rate is high when compared to the H1N1pdm09 (pandemic Influenza
A virus H1N1 subtype) rate, and although both cause an aggravated inflammatory response …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human cell, 2020 - Springer
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Underlying vulnerabilities to the cytokine storm and adverse COVID-19 outcomes in the aging immune system

LS Nidadavolu, JD Walston - The Journals of Gerontology …, 2021 - academic.oup.com
Older adults are far more vulnerable to adverse health outcomes and mortality after
contracting COVID-19. There are likely multiple age-related biological, clinical, and …

Vitamin D and COVID‐19: role of ACE2, age, gender, and ethnicity

B Getachew, Y Tizabi - Journal of medical virology, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) virus, disproportionally targets older people …

Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19

G Costagliola, E Spada… - … inflammation and disease, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), can present with a wide spectrum of
severity. Elderly patients with cardiac, pulmonary and metabolic comorbidities are more …

The mechanism of multiple organ dysfunction syndrome in patients with COVID‐19

W Zhao, H Li, J Li, B Xu, J Xu - Journal of medical virology, 2022 - Wiley Online Library
In late 2019, an outbreak of coronavirus disease 2019 (COVID‐19) arose, caused by severe
acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2). This disease rapidly became …

Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of vitamin-D

MY Peng, WC Liu, JQ Zheng, CL Lu, YC Hou… - International journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is still an ongoing global health crisis. Immediately after the …

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

C Lee, WJ Choi - Archives of pharmacal research, 2021 - Springer
The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …

[HTML][HTML] SARS-CoV-2 infection of airway epithelial cells

G Ryu, HW Shin - Immune network, 2021 - ncbi.nlm.nih.gov
Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has been spreading worldwide since its outbreak in December 2019, and …